-
Adapting vision–language AI models to cardiology tasks Nat. Med. (IF 82.9) Pub Date : 2024-05-01 Rima Arnaout
Vision–language models can be trained to read cardiac ultrasound images with implications for improving clinical workflows, but additional development and validation will be required before such models can replace humans.
-
Exome sequencing reveals genetic heterogeneity and clinically actionable findings in children with cerebral palsy Nat. Med. (IF 82.9) Pub Date : 2024-05-01 Yangong Wang, Yiran Xu, Chongchen Zhou, Ye Cheng, Niu Qiao, Qing Shang, Lei Xia, Juan Song, Chao Gao, Yimeng Qiao, Xiaoli Zhang, Ming Li, Caiyun Ma, Yangyi Fan, Xirui Peng, Silin Wu, Nan Lv, Bingbing Li, Yanyan Sun, Bohao Zhang, Tongchuan Li, Hongwei Li, Jin Zhang, Yu Su, Qiaoli Li, Junying Yuan, Lei Liu, Andres Moreno-De-Luca, Alastair H. MacLennan, Jozef Gecz, Dengna Zhu, Xiaoyang Wang, Changlian
-
Reverse total shoulder replacement versus anatomical total shoulder replacement for osteoarthritis: population based cohort study using data from the National Joint Registry and Hospital Episode Statistics for England BMJ (IF 105.7) Pub Date : 2024-04-30 Epaminondas Markos Valsamis, Albert Prats-Uribe, Ian Koblbauer, Sophie Cole, Adrian Sayers, Michael R Whitehouse, Gillian Coward, Gary S Collins, Rafael Pinedo-Villanueva, Daniel Prieto-Alhambra, Jonathan L Rees
Objectives To answer a national research priority by comparing the risk-benefit and costs associated with reverse total shoulder replacement (RTSR) and anatomical total shoulder replacement (TSR) in patients having elective primary shoulder replacement for osteoarthritis. Design Population based cohort study using data from the National Joint Registry and Hospital Episode Statistics for England. Setting
-
Irritable bowel syndrome: low dose antidepressant improves symptoms BMJ (IF 105.7) Pub Date : 2024-05-01 Helen Saul, Samantha Cassidy, Laura Swaithes, Alex Ford
Ford AC, Wright-Hughes A, Alderson SL, et al. Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2023;402:1773-85. To read the full NIHR Alert, go to:
-
Fluoroquinolones: clearer evidence and guidance on safety are needed BMJ (IF 105.7) Pub Date : 2024-05-01 Fergus Hamilton, Elizabeth Darley, Alasdair MacGowan
Guidance on drug safety from regulatory agencies must be sensibly communicated and based on strong, clear evidence Doctors learn early in their careers about the central importance of communication in medicine. Discussion of the relative risks and benefits of various treatment options, while considering the wider evidence and an individual patient’s circumstances and views, is challenging. The same
-
Early diagnosis is not always an unmitigated good, we need to make it useful for patients and clinicians BMJ (IF 105.7) Pub Date : 2024-05-01 Margaret McCartney, Peter J Liu, Anne Fearfull, Helen Macdonald, Peter D Donnelly
We need to define the concept of early diagnosis The importance of early diagnosis, particularly in cancer, has been covered widely in the media. Improving early diagnosis rates is a politically popular target. Innovation and new technology have also been proposed by the government—for example, through Academic Health Science Networks—as means to stimulate economic growth. UK policy emphasises the
-
Scottish parliament did not lack courage in voting against assisted suicide bill in 2015 BMJ (IF 105.7) Pub Date : 2024-04-30 Mary Neal
Warlow, a trustee of the pro-assisted dying campaign group Friends at the End, welcomes the introduction of the Assisted Dying for Terminally Ill Adults (Scotland) Bill, but wonders if members of the Scottish parliament will have the “courage to legislate in the direction which the public clearly want,” or if they will “hold back sheepishly like last time, under pressure from a minority of well meaning
-
Reduce waste in the NHS to deliver population health BMJ (IF 105.7) Pub Date : 2024-05-01 Muir Gray, Anant Jani, Alf Collins
A cash injection of £32bn to the NHS might be what The BMJ wants,1 but it is not what England needs. The people of England need The BMJ to work with the Department of Health and Social Care and the NHS to identify and disinvest from unnecessary, and often harmful, prescriptions, tests, and treatments on which vast amounts of finite taxpayers’ money are being wasted. In 2017, the Organisation for Economic
-
What do we know about covid-19’s effects on the gut? BMJ (IF 105.7) Pub Date : 2024-05-01 Katharine Lang
Not just a respiratory infection, covid can cause symptoms throughout the body. Gastrointestinal symptoms are common in both acute and long covid, with gut issues often persisting long after initial infection. Katharine Lang investigates Lack of appetite, nausea, vomiting, diarrhoea, and abdominal pain. These may not be the symptoms people expect with covid, but around 50% of people experience them
-
Choosing the best shoulder replacement BMJ (IF 105.7) Pub Date : 2024-04-30 Jonathan P Evans, Christopher D Smith, Jonathan T Evans
New analyses fill an important evidence gap while we wait for trials In 2020, the National Institute for Health and Care Research commissioned the randomised RAPSODI trial, aiming to find the best type of joint replacement for the treatment of painful osteoarthritis of the shoulder. This trial commenced in 2022, but will not report its results until the spring of 2027 at the eaanatorliest.1 In a linked
-
Clinical effectiveness of an online supervised group physical and mental health rehabilitation programme for adults with post-covid-19 condition (REGAIN study): multicentre randomised controlled trial BMJ (IF 105.7) Pub Date : 2024-05-01 British Medical Journal Publishing Group
Several sections of this paper by McGregor and colleagues ( BMJ 2024;385:e076506, doi:10.1136/bmj-2023-076506, published 7 February 2024) have been updated for clarity of the study population. …
-
Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors CA: Cancer J. Clin. (IF 254.7) Pub Date : 2024-04-29 Aman Chauhan, Kelley Chan, Thorvardur R. Halfdanarson, Andrew M. Bellizzi, Guido Rindi, Dermot O’Toole, Phillip S. Ge, Dhanpat Jain, Arvind Dasari, Daniel A. Anaya, Emily Bergsland, Erik Mittra, Alice C. Wei, Thomas A. Hope, Ayse T. Kendi, Samantha M. Thomas, Sherlonda Flem, James Brierley, Elliot A. Asare, Kay Washington, Chanjuan Shi
The American Joint Committee on Cancer (AJCC) staging system for all cancer sites, including gastroenteropancreatic neuroendocrine tumors (GEP-NETs), is meant to be dynamic, requiring periodic updates to optimize AJCC staging definitions. This entails the collaboration of experts charged with evaluating new evidence that supports changes to each staging system. GEP-NETs are the second most prevalent
-
The search for authentic microbiome–disease relationships Nat. Med. (IF 82.9) Pub Date : 2024-04-30 Na Jiao, Lixin Zhu, Ruixin Zhu
-
Life-long health consequences of undernutrition in the Yanomami indigenous population in Brazil Nat. Med. (IF 82.9) Pub Date : 2024-04-30 Thiago dos Reis Araujo, Ana Paula Davel, Everardo Magalhães Carneiro
-
Sustainable, low-cost cancer diagnostics Nat. Med. (IF 82.9) Pub Date : 2024-04-30
Researchers have developed a low-resource, environmentally friendly cancer-diagnosis platform that detects metabolites in dried serum spots.
-
Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children Nat. Med. (IF 82.9) Pub Date : 2024-04-30 Youjia Zhong, Alicia Y. H. Kang, Carina J. X. Tay, Hui’ En Li, Nurul Elyana, Chee Wah Tan, Wee Chee Yap, Joey M. E. Lim, Nina Le Bert, Kuan Rong Chan, Eugenia Z. Ong, Jenny G. Low, Lynette P. Shek, Elizabeth Huiwen Tham, Eng Eong Ooi
-
Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial Nat. Med. (IF 82.9) Pub Date : 2024-04-30 Martin Schuler, Kristof Cuppens, Till Plönes, Marcel Wiesweg, Bert Du Pont, Balazs Hegedus, Johannes Köster, Fabian Mairinger, Kaid Darwiche, Annette Paschen, Brigitte Maes, Michel Vanbockrijck, David Lähnemann, Fang Zhao, Hubertus Hautzel, Dirk Theegarten, Koen Hartemink, Henning Reis, Paul Baas, Alexander Schramm, Clemens Aigner
-
Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development Nat. Med. (IF 82.9) Pub Date : 2024-04-30 Raúl Y. Tito, Sara Verbandt, Marta Aguirre Vazquez, Leo Lahti, Chloe Verspecht, Verónica Lloréns-Rico, Sara Vieira-Silva, Janine Arts, Gwen Falony, Evelien Dekker, Joke Reumers, Sabine Tejpar, Jeroen Raes
-
Vision–language foundation model for echocardiogram interpretation Nat. Med. (IF 82.9) Pub Date : 2024-04-30 Matthew Christensen, Milos Vukadinovic, Neal Yuan, David Ouyang
-
Dementia, like any condition, warrants conversations about risks and prevention BMJ (IF 105.7) Pub Date : 2024-04-29 David Ensor
GPs are missing an opportunity to champion brain health, writes David Ensor Dementia is a condition that is widely misunderstood by many people.1 Admittedly, my knowledge of dementia was limited until my late wife, Susan, received the diagnosis of Alzheimer’s disease. That’s when it became all too real. When I’ve spoken to other people who’ve been affected by dementia, the word “inevitable” often crops
-
What will it take for a new sanitary revolution in the UK? BMJ (IF 105.7) Pub Date : 2024-04-29 John Middleton, Patrick Saunders
Sanitation is an essential public health service, so where is the outrage at the pollution of England’s waterways, ask these authors Recently the dire state of the UK’s rivers was highlighted once again when rowers in the annual Oxford vs Cambridge boat race were taken unwell. They criticised the levels of sewage and high rates of e-coli in the river Thames.1 The organisers of the boat race declared
-
Helen Salisbury: Continuity and learning from experience BMJ (IF 105.7) Pub Date : 2024-04-30 Helen Salisbury
Continuity of care—seeing the same GP over time—reduces the need for emergency care and increases longevity in patients.1 It leads to better patient satisfaction and improved quality of care.2 It also has the potential to make GPs into better doctors—not just for the individual patient in front of us, as we learn more about their life and gain their trust, but by deepening our understanding of medicine
-
Rammya Mathew: We can’t overlook the backdrop as Britain becomes “a sicker nation” BMJ (IF 105.7) Pub Date : 2024-04-30 Rammya Mathew
Plans by the prime minister, Rishi Sunak, to overhaul the sick note system in the UK have left me with mixed emotions. A more independent process, overseen by professionals skilled in occupational health, will hopefully lead to a more robust system, in which people are supported to get back into work as quickly as possible, when they feel able to. But I worry that removing GPs from the decision making
-
Say hello to patients: patients can encourage introductions BMJ (IF 105.7) Pub Date : 2024-04-30 Judith H Harvey
Launer suggests clinicians “cultivate a routine of looking directly at every patient they pass” …
-
Perhaps politicians and health leaders could #sayhellotopatients? BMJ (IF 105.7) Pub Date : 2024-04-30 Jamie M Sillett
Launer encourages clinicians to acknowledge every patient they pass, making eye contact “if not actually saying hello every time.”1 While I recognise the positive impact making eye contact and acknowledging patients could bring, the article does not recognise how …
-
Taking racism out of clinical guidelines BMJ (IF 105.7) Pub Date : 2024-04-30 Alexander Mafi, Habib Naqvi, Veline L’Esperance
Guidelines should be reviewed to identify inappropriate use of race and ethnicity Health systems continue to grapple with the deeply rooted consequences of systemic racism within healthcare. The immediacy of this challenge is evidenced in the recent Whitehead report,1 published in the UK, which highlights ethnic inequalities arising from the design and calibration of medical devices. Internationally
-
Health systems and environmental sustainability: updating frameworks for a new era BMJ (IF 105.7) Pub Date : 2024-04-30 Michael Padget, Michael A Peters, Matthias Brunn, Dionne Kringos, Margaret E Kruk
Michael Padget and colleagues argue that making environmental sustainability a measure of health system quality will support progress and help fulfil systems’ fundamental mission to protect and improve health Healthcare systems around the world have a responsibility to “do no harm” but are responsible for substantial negative health effects through the production of greenhouse gases, particulate matter
-
Screening for Breast Cancer JAMA (IF 120.7) Pub Date : 2024-04-30 Jillian T. Henderson, Elizabeth M. Webber, Meghan S. Weyrich, Marykate Miller, Joy Melnikow
ImportanceBreast cancer is a leading cause of cancer mortality for US women. Trials have established that screening mammography can reduce mortality risk, but optimal screening ages, intervals, and modalities for population screening guidelines remain unclear.ObjectiveTo review studies comparing different breast cancer screening strategies for the US Preventive Services Task Force.Data SourcesMEDLINE
-
Collaborative Modeling to Compare Different Breast Cancer Screening Strategies JAMA (IF 120.7) Pub Date : 2024-04-30 Amy Trentham-Dietz, Christina Hunter Chapman, Jinani Jayasekera, Kathryn P. Lowry, Brandy M. Heckman-Stoddard, John M. Hampton, Jennifer L. Caswell-Jin, Ronald E. Gangnon, Ying Lu, Hui Huang, Sarah Stein, Liyang Sun, Eugenio J. Gil Quessep, Yuanliang Yang, Yifan Lu, Juhee Song, Diego F. Muñoz, Yisheng Li, Allison W. Kurian, Karla Kerlikowske, Ellen S. O’Meara, Brian L. Sprague, Anna N. A. Tosteson
ImportanceThe effects of breast cancer incidence changes and advances in screening and treatment on outcomes of different screening strategies are not well known.ObjectiveTo estimate outcomes of various mammography screening strategies.Design, Setting, and PopulationComparison of outcomes using 6 Cancer Intervention and Surveillance Modeling Network (CISNET) models and national data on breast cancer
-
Antigenic distance between primary and secondary dengue infections correlates with disease risk Sci. Transl. Med. (IF 17.1) Pub Date : 2024-04-24 Lin Wang, Angkana T. Huang, Leah C. Katzelnick, Noémie Lefrancq, Ana Coello Escoto, Loréna Duret, Nayeem Chowdhury, Richard Jarman, Matthew A. Conte, Irina Maljkovic Berry, Stefan Fernandez, Chonticha Klungthong, Butsaya Thaisomboonsuk, Piyarat Suntarattiwong, Warunee Vandepitte, Stephen S. Whitehead, Simon Cauchemez, Derek A. T. Cummings, Henrik Salje
Many pathogens continuously change their protein structure in response to immune-driven selection, resulting in weakened protection even in previously exposed individuals. In addition, for some pathogens, such as dengue virus, poorly targeted immunity is associated with increased risk of severe disease through a mechanism known as antibody-dependent enhancement. However, it remains unclear whether
-
Telemonitoring of patients with acute coronary syndrome Nat. Med. (IF 82.9) Pub Date : 2024-04-29
A randomized controlled trial involving a telemedicine-based approach for the management of patients with acute coronary syndrome had several clinical benefits relative to standard of care.
-
AI-enabled electrocardiography alert intervention and all-cause mortality: a pragmatic randomized clinical trial Nat. Med. (IF 82.9) Pub Date : 2024-04-29 Chin-Sheng Lin, Wei-Ting Liu, Dung-Jang Tsai, Yu-Sheng Lou, Chiao-Hsiang Chang, Chiao-Chin Lee, Wen-Hui Fang, Chih-Chia Wang, Yen-Yuan Chen, Wei-Shiang Lin, Cheng-Chung Cheng, Chia-Cheng Lee, Chih-Hung Wang, Chien-Sung Tsai, Shih-Hua Lin, Chin Lin
-
The health risks of generative AI-based wellness apps Nat. Med. (IF 82.9) Pub Date : 2024-04-29 Julian De Freitas, I. Glenn Cohen
-
Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023 Nat. Med. (IF 82.9) Pub Date : 2024-04-29 Jeffrey V. Lazarus, Trenton M. White, Katarzyna Wyka, Scott C. Ratzan, Kenneth Rabin, Heidi J. Larson, Federico Martinon-Torres, Ernest Kuchar, Salim S. Abdool Karim, Tamara Giles-Vernick, Selina Müller, Carolina Batista, Nellie Myburgh, Beate Kampmann, Ayman El-Mohandes
-
Disability community feels ignored in Canada’s assisted dying expansion BMJ (IF 105.7) Pub Date : 2024-04-29 Sammy Chown
Plans to expand one of the world’s most permissive assisted dying laws have been postponed by the Canadian government, reigniting debate about the country’s stance. Sammy Chown reports On 29 February, Canada’s ruling Liberal Party confirmed that a proposed expansion of its medical assistance in dying (MAID) measures would be delayed for a second time.1 Originally proposed in a 2021 amendment to the
-
Teaching beyond retirement: the consultant neuroradiologist BMJ (IF 105.7) Pub Date : 2024-04-29 Adrian O’Dowd
Consultant neuroradiologist Ian Turnbull tells Adrian O’Dowd why he was determined to remain involved in training doctors despite retiring Retirement does not mean a doctor has to stop loving medicine or wanting to be involved in training the next generation of clinicians, says Ian Turnbull. Edinburgh born Turnbull was a consultant neuroradiologist at North Manchester General Hospital for 19 years
-
Global Production of Active Pharmaceutical Ingredients for US Generic Drugs Experiencing Shortages JAMA (IF 120.7) Pub Date : 2024-04-29 Mariana P. Socal, Matthew A. Crane, Gerard F. Anderson
This study evaluates the characteristics of generic active pharmaceutical ingredients (APIs) used to manufacture drugs with shortages in the US and facilities producing APIs worldwide.
-
At-Home Diagnostics Solutions for Chlamydia and Gonorrhea JAMA (IF 120.7) Pub Date : 2024-04-29 Ellen N. Kersh, Leandro A. Mena
This Viewpoint discusses the US Food and Drug Administration’s authorization of marketing an at-home testing system for chlamydia and gonorrhea as a good first step in boosting access to screening and treatment and in reducing infection rates.
-
Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer JAMA (IF 120.7) Pub Date : 2024-04-29 Wendy Y. Chen, Karla V. Ballman, Ann H. Partridge, Olwen M. Hahn, Frederick M. Briccetti, William J. Irvin, Banu Symington, Kala Visvanathan, Paula R. Pohlmann, Thomas H. Openshaw, Anna Weiss, Eric P. Winer, Lisa A. Carey, Michelle D. Holmes
ImportanceObservational studies of survivors of breast cancer and prospective trials of aspirin for cardiovascular disease suggest improved breast cancer survival among aspirin users, but prospective studies of aspirin to prevent breast cancer recurrence are lacking.ObjectiveTo determine whether aspirin decreases the risk of invasive cancer events among survivors of breast cancer.Design, Setting, and
-
Journal Voices in the Civil Rights Era — New Horizons and Limits in Medical Publishing N. Engl. J. Med. (IF 158.5) Pub Date : 2024-04-27 Merlin Chowkwanyun From the Mailman School of Public Health, Columbia University, New York.
During the social tumult of the 1960s and 1970s, the Journal opened its pages to advocates of reform in the profession and society at large, but it did not completely break with its troubled racial...
-
Acute Promyelocytic Leukemia N. Engl. J. Med. (IF 158.5) Pub Date : 2024-04-27 Christoph Winkler Tirol Kliniken, Innsbruck, Austria
A 47-year-old man presented with 2-day history of weakness and fever. Laboratory studies showed pancytopenia. A bone marrow biopsy showed promyelocytes with abundant intracellular rods.
-
Inhibiting Eph/ephrin signaling reduces vascular leak and endothelial cell dysfunction in mice with sepsis Sci. Transl. Med. (IF 17.1) Pub Date : 2024-04-24 Nemat Khan, Vinod Kumar, Pengcheng Li, RAPIDS Study Group, Luregn J. Schlapbach, Andrew W. Boyd, Mark G. Coulthard, Trent M. Woodruff
Sepsis is a life-threatening disease caused by a dysregulated host response to infection, resulting in 11 million deaths globally each year. Vascular endothelial cell dysfunction results in the loss of endothelial barrier integrity, which contributes to sepsis-induced multiple organ failure and mortality. Erythropoietin-producing hepatocellular carcinoma (Eph) receptors and their ephrin ligands play
-
The Quest for Transformative Tools to Eradicate Malaria N. Engl. J. Med. (IF 158.5) Pub Date : 2024-05-02 Trevor Mundel From the Bill and Melinda Gates Foundation, Seattle.
We in the global malaria community are at a critical juncture in our journey toward malaria eradication. Decades of experience in deploying our existing interventions have made it clear that there ...
-
Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria N. Engl. J. Med. (IF 158.5) Pub Date : 2024-05-02 Kassoum Kayentao, Aissata Ongoiba, Anne C. Preston, Sara A. Healy, Zonghui Hu, Jeff Skinner, Safiatou Doumbo, Jing Wang, Hamidou Cisse, Didier Doumtabe, Abdrahamane Traore, Hamadi Traore, Adama Djiguiba, Shanping Li, Mary E. Peterson, Shinyi Telscher, Azza H. Idris, William C. Adams, Adrian B. McDermott, Sandeep Narpala, Bob C. Lin, Leonid Serebryannyy, Somia P. Hickman, Andrew J. McDougal, Sandra
Subcutaneous administration of the monoclonal antibody L9LS protected adults against controlled Plasmodium falciparum infection in a phase 1 trial. Whether a monoclonal antibody administered subcut...
-
The drama of psychoanalysis BMJ (IF 105.7) Pub Date : 2024-04-26 Richard Smith
Henry Miller, the witty and now dead neurologist from Newcastle, said that one of the great challenges for 21st century medical historians would be to explain the obsession with psychoanalysis in the 20th century. How did thinking what was more cult than science take over American psychiatry and bewitch intellectuals? Seamus O’Mahony doesn’t specifically set out to answer that question in his wonderfully
-
Cancer diagnosis and treatment in working-age adults: Implications for employment, health insurance coverage, and financial hardship in the United States CA: Cancer J. Clin. (IF 254.7) Pub Date : 2024-04-23 K. Robin Yabroff, Joanna F. Doran, Jingxuan Zhao, Fumiko Chino, Ya-Chen Tina Shih, Xuesong Han, Zhiyuan Zheng, Cathy J. Bradley, Monica F. Bryant
The rising costs of cancer care and subsequent medical financial hardship for cancer survivors and families are well documented in the United States. Less attention has been paid to employment disruptions and loss of household income after a cancer diagnosis and during treatment, potentially resulting in lasting financial hardship, particularly for working-age adults not yet age-eligible for Medicare
-
The argument framework is a flexible approach to evidence in healthcare Nat. Med. (IF 82.9) Pub Date : 2024-04-26 Jonathan Fuller, Benjamin Chin-Yee, Ross E. G. Upshur
-
Bispecific T cell engager therapy for refractory rheumatoid arthritis Nat. Med. (IF 82.9) Pub Date : 2024-04-26 Laura Bucci, Melanie Hagen, Tobias Rothe, Maria Gabriella Raimondo, Filippo Fagni, Carlo Tur, Andreas Wirsching, Jochen Wacker, Artur Wilhelm, Jean-Philippe Auger, Milena Pachowsky, Markus Eckstein, Stefano Alivernini, Angelo Zoli, Gerhard Krönke, Stefan Uderhardt, Aline Bozec, Maria-Antonietta D’Agostino, Georg Schett, Ricardo Grieshaber-Bouyer
-
When I use a word . . . The languages of medicines—British Approved Names BMJ (IF 105.7) Pub Date : 2024-04-26 Jeffrey K Aronson
Approved names of medicines, later known as British Approved Names, were introduced in the UK in the 1940s, as part of wartime efforts to ensure the supply of important medicines, including antimalarial drugs manufactured in Germany. Giving them approved names allowed any manufacturer to market a product containing the medicine, which would otherwise only be available as a branded product. Such products
-
It’s early days in the collaborative process of reforming medical education and training BMJ (IF 105.7) Pub Date : 2024-04-25 Colin Melville
Oliver and Vaughan outline their concerns about the General Medical Council’s vision for reforming education and training.1 They focused on the areas of change we set out, but ignored the principles that underpin our regulatory approach—patient safety; maintaining standards; outcomes, not time; competency; proportionality; and support for diversity. By not taking these into account they misunderstand
-
Medscape caves in on courses funded by tobacco giant Philip Morris, while medics fear global push into medical education BMJ (IF 105.7) Pub Date : 2024-04-26 Hristio Boytchev
Clinic demonstrations, podcasts, and TV shows: Hristio Boytchev reveals how an ambitious deal between a leading medical education provider and the tobacco industry collapsed this week The medical education provider Medscape has bowed to pressure and agreed to permanently remove a series of accredited medical education courses on smoking cessation funded by the tobacco industry giant Philip Morris International
-
Stop tobacco industry sponsorship of continuing medical education BMJ (IF 105.7) Pub Date : 2024-04-26 Ruth E Malone
This malign industry must not be allowed to influence clinicians’ learning In a troubling development for tobacco control, Medscape, a continuing education website for health professionals, was recently discovered to be promoting a series on smoking cessation sponsored by tobacco company Philip Morris International (PMI).1 Observers will note the bizarre incongruity of education programmes for doctors
-
Achieving more equitable access to assisted reproduction BMJ (IF 105.7) Pub Date : 2024-04-26 Silke J Dyer, G David Adamson, Marcia C Inhorn, Fernando Zegers-Hochschild
Equitable access to fertility care must be recognised as a human right so that it can be better balanced with other societal needs, say Silke Dyer , David Adamson , Marcia Inhorn, and Fernando Zegers-Hochschild Infertility affects one in six people in their lifetime yet remains a neglected global health problem.1 The World Health Organization (WHO) recognises infertility as a disease and has highlighted
-
False Health Claims Abound, but Physicians Are Still the Most Trusted Source for Health Information JAMA (IF 120.7) Pub Date : 2024-04-26 Melissa Suran, Karen Bucher
This Medical News article discusses a KFF poll about the public’s exposure to and beliefs about inaccurate health information, as well as media use and trust in sources.
-
The Public Good on the Docket — The Supreme Court’s Evolving Approach to Public Health N. Engl. J. Med. (IF 158.5) Pub Date : 2024-04-24 Joshua M. Sharfstein, and Lawrence O. Gostin From the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore (J.M.S.), and the O’Neill Institute for National and Global Health Law, Georgetown University Law Center, Washington, DC (L.O.G.).
The Supreme Court has imposed new legal principles that impede the ability of states, Congress, and agencies to use evidence to protect the public. It now has the opportunity to reconsider this app...
-
Reproductive rights in the United States: acquiescence is not a strategy Nat. Med. (IF 82.9) Pub Date : 2024-04-25 Laura J. Esserman, Douglas Yee
Scientific and medical conferences should not be held in states that ban abortion, as such bans put the lives of women at risk.
-
Large language models for preventing medication direction errors in online pharmacies Nat. Med. (IF 82.9) Pub Date : 2024-04-25 Cristobal Pais, Jianfeng Liu, Robert Voigt, Vin Gupta, Elizabeth Wade, Mohsen Bayati
-
Urgent action is needed to confront artemisinin partial resistance in African malaria parasites Nat. Med. (IF 82.9) Pub Date : 2024-04-25
Discover the world’s best science and medicine | Nature.com
-
Welcoming the Era of Gene Editing in Medicine N. Engl. J. Med. (IF 158.5) Pub Date : 2024-04-24 George Q. Daley From Boston Children’s Hospital and Harvard Medical School — both in Boston.
Recent approvals of exa-cel for treatment of sickle cell disease and transfusion-dependent β-thalassemia mark the dawn of the era of gene editing in medicine. But ensuring access will be challenging.
-
Extending Gene Medicines to All in Need N. Engl. J. Med. (IF 158.5) Pub Date : 2024-04-24 Joseph M. McCune, and Hans-Peter Kiem From the Global Health Division, Bill and Melinda Gates Foundation (J.M.M.), and the Fred Hutchinson Cancer Center and University of Washington School of Medicine (H.-P.K.) — all in Seattle.
Sixty years ago, Fessas and Stamatoyannopoulos noticed that patients with hereditary persistence of fetal hemoglobin have a milder course of β-thalassemia than other patients with the condition.1 L...